U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 42

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr14:21162091
GRCh38:
Chr14:20693932
ANG, EGILA, RNASE4G123EAmyotrophic lateral sclerosis type 9Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
2.
GRCh37:
Chr14:21161947
GRCh38:
Chr14:20693788
ANG, EGILA, RNASE4R75Hnot provided, Amyotrophic lateral sclerosis type 9Uncertain significance
(Feb 25, 2022)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr14:21161785
GRCh38:
Chr14:20693626
ANG, EGILA, RNASE4P21LAmyotrophic lateral sclerosis type 9, not providedUncertain significance
(Jan 26, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr14:21161785
GRCh38:
Chr14:20693626
ANG, EGILA, RNASE4P21QAmyotrophic lateral sclerosis type 9, not providedBenign/Likely benign
(Apr 20, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr14:21161761
GRCh38:
Chr14:20693602
ANG, EGILA, RNASE4V13AAmyotrophic lateral sclerosis type 9Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
6.
GRCh37:
Chr14:21161702
GRCh38:
Chr14:20693543
ANG, EGILA, RNASE4Amyotrophic lateral sclerosis type 9Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
7.
GRCh37:
Chr14:21152768
GRCh38:
Chr14:20684609
ANG, RNASE4Amyotrophic lateral sclerosis type 9Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
8.
GRCh37:
Chr14:21162306
GRCh38:
Chr14:20694147
ANG, EGILA, RNASE4Amyotrophic lateral sclerosis type 9Likely benign
(Jan 13, 2018)
criteria provided, single submitter
9.
GRCh37:
Chr14:21162248
GRCh38:
Chr14:20694089
ANG, EGILA, RNASE4Amyotrophic lateral sclerosis type 9Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
10.
GRCh37:
Chr14:21152394
GRCh38:
Chr14:20684235
ANGAmyotrophic lateral sclerosis type 9Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
11.
GRCh37:
Chr14:21161726
GRCh38:
Chr14:20693567
ANG, EGILA, RNASE4M1IANG-related condition, Amyotrophic lateral sclerosis type 10, not provided,
Amyotrophic lateral sclerosis type 9
Conflicting interpretations of pathogenicity
(Oct 21, 2022)
criteria provided, conflicting interpretations
12.
GRCh37:
Chr14:21162177
GRCh38:
Chr14:20694018
ANG, EGILA, RNASE4Amyotrophic lateral sclerosis type 9Likely benign
(Jan 13, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr14:21162164
GRCh38:
Chr14:20694005
ANG, EGILA, RNASE4Amyotrophic lateral sclerosis type 9Likely benign
(Jan 13, 2018)
criteria provided, single submitter
14.
GRCh37:
Chr14:21162088
GRCh38:
Chr14:20693929
ANG, EGILA, RNASE4A122VAmyotrophic lateral sclerosis type 9Likely benign
(Jan 13, 2018)
criteria provided, single submitter
15.
GRCh37:
Chr14:21162086
GRCh38:
Chr14:20693927
ANG, EGILA, RNASE4Amyotrophic lateral sclerosis type 9, not providedBenign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr14:21161973
GRCh38:
Chr14:20693814
ANG, EGILA, RNASE4K84Enot specified, Amyotrophic lateral sclerosis type 9, not provided
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr14:21161822
GRCh38:
Chr14:20693663
RNASE4, ANG, EGILAAmyotrophic lateral sclerosis type 9, Inborn genetic diseases, not provided
Benign/Likely benign
(Oct 7, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr14:21152928
GRCh38:
Chr14:20684769
ANG, LOC130055270, RNASE4Amyotrophic lateral sclerosis type 9Likely benign
(Jan 12, 2018)
criteria provided, single submitter
19.
GRCh37:
Chr14:21152895
GRCh38:
Chr14:20684736
ANG, LOC130055270, RNASE4Amyotrophic lateral sclerosis type 9Benign
(Jan 13, 2018)
criteria provided, single submitter
20.
GRCh37:
Chr14:21152821
GRCh38:
Chr14:20684662
ANG, RNASE4Amyotrophic lateral sclerosis type 9Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr14:21152699
GRCh38:
Chr14:20684540
ANGAmyotrophic lateral sclerosis type 9Benign
(Jan 13, 2018)
criteria provided, single submitter
22.
GRCh37:
Chr14:21152604
GRCh38:
Chr14:20684445
ANG, LOC130055269Amyotrophic lateral sclerosis type 9Benign
(Jan 12, 2018)
criteria provided, single submitter
23.
GRCh37:
Chr14:21152555
GRCh38:
Chr14:20684396
LOC130055269, ANGAmyotrophic lateral sclerosis type 9Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
24.
GRCh37:
Chr14:21152553
GRCh38:
Chr14:20684394
ANG, LOC130055269Amyotrophic lateral sclerosis type 9Benign
(Jan 13, 2018)
criteria provided, single submitter
25.
GRCh37:
Chr14:21152535
GRCh38:
Chr14:20684376
ANG, LOC130055269Amyotrophic lateral sclerosis type 9Benign
(Jan 13, 2018)
criteria provided, single submitter
26.
GRCh37:
Chr14:21152513
GRCh38:
Chr14:20684354
ANGAmyotrophic lateral sclerosis type 9Benign
(Jan 12, 2018)
criteria provided, single submitter
27.
GRCh37:
Chr14:21152412
GRCh38:
Chr14:20684253
ANGAmyotrophic lateral sclerosis type 9Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
28.
GRCh37:
Chr14:21152406
GRCh38:
Chr14:20684247
ANGAmyotrophic lateral sclerosis type 9Benign
(Jan 12, 2018)
criteria provided, single submitter
29.
GRCh37:
Chr14:21152402
GRCh38:
Chr14:20684243
ANGAmyotrophic lateral sclerosis type 9Benign
(Jan 13, 2018)
criteria provided, single submitter
30.
GRCh37:
Chr14:21152357
GRCh38:
Chr14:20684198
ANGAmyotrophic lateral sclerosis type 9Benign
(Jan 12, 2018)
criteria provided, single submitter
31.
GRCh37:
Chr14:21152342
GRCh38:
Chr14:20684183
ANGAmyotrophic lateral sclerosis type 9Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
32.
GRCh37:
Chr14:21162053
GRCh38:
Chr14:20693894
ANG, EGILA, RNASE4Inborn genetic diseases, Amyotrophic lateral sclerosis type 9, not specified,
not provided
Benign/Likely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr14:21162132
GRCh38:
Chr14:20693973
ANG, EGILA, RNASE4V137IAmyotrophic lateral sclerosis type 9Pathogenic
(Feb 1, 2008)
no assertion criteria provided
34.
GRCh37:
Chr14:21162130
GRCh38:
Chr14:20693971
ANG, EGILA, RNASE4P136LANG-related condition, Amyotrophic lateral sclerosis type 9Conflicting interpretations of pathogenicity
(Aug 6, 2023)
criteria provided, conflicting interpretations
35.
GRCh37:
Chr14:21161878
GRCh38:
Chr14:20693719
ANG, EGILA, RNASE4S52NAmyotrophic lateral sclerosis type 9Likely pathogenic
(Aug 30, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr14:21161931
GRCh38:
Chr14:20693772
ANG, EGILA, RNASE4I70Vnot specified, not provided, Amyotrophic lateral sclerosis type 9
Conflicting interpretations of pathogenicity
(Oct 9, 2022)
criteria provided, conflicting interpretations
37.
GRCh37:
Chr14:21161914
GRCh38:
Chr14:20693755
ANG, EGILA, RNASE4K64IAmyotrophic lateral sclerosis type 9Pathogenic
(Apr 1, 2006)
no assertion criteria provided
38.
GRCh37:
Chr14:21161912
GRCh38:
Chr14:20693753
ANG, EGILA, RNASE4C63WAmyotrophic lateral sclerosis type 9Pathogenic
(Apr 1, 2006)
no assertion criteria provided
39.
GRCh37:
Chr14:21161887
GRCh38:
Chr14:20693728
ANG, EGILA, RNASE4R55KAmyotrophic lateral sclerosis type 9Pathogenic
(Apr 1, 2006)
no assertion criteria provided
40.
GRCh37:
Chr14:21161844
GRCh38:
Chr14:20693685
ANG, EGILA, RNASE4K41EAmyotrophic lateral sclerosis type 9Pathogenic
(Apr 1, 2006)
no assertion criteria provided
41.
GRCh37:
Chr14:21161845
GRCh38:
Chr14:20693686
ANG, EGILA, RNASE4K41Inot specified, not provided, Amyotrophic lateral sclerosis type 9
Conflicting interpretations of pathogenicity
(Oct 1, 2023)
criteria provided, conflicting interpretations
42.
GRCh37:
Chr14:21161830
GRCh38:
Chr14:20693671
ANG, EGILA, RNASE4Q36LAmyotrophic lateral sclerosis type 9Pathogenic
(Apr 1, 2006)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination